Wize Pharma

Wize Pharma R&D Expenses

Delisted·Jan 10, 2019

The Research & Development Expenses of Wize Pharma (WIZP) as of Nov 19, 2026 is 434,000.00 USD. In the previous year, Research & Development Expenses was 492,000.00 USD — a change of -11.79% (lower).

R&D Expenses

434,000.00USD

YoY

-11.79%

Last updated:

Research & Development Expenses of Wize Pharma is 2020 434,000.00 USD. Research & Development Expenses of Wize Pharma was 2019 492,000.00 USD. It decreases by -11.79% lower compared to the previous year.

The Wize Pharma R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2014
240,000.00 USD
Jan 1, 2015
240,000.00 USD
Jan 1, 2016
199,000.00 USD
Jan 1, 2017
450,000.00 USD
Jan 1, 2018
694,000.00 USD
Jan 1, 2019
492,000.00 USD
Jan 1, 2020
434,000.00 USD
The Wize Pharma R&D Expenses history
YEARR&D ExpensesYoY
434,000.00USD-11.79%
492,000.00USD-29.11%
694,000.00USD+54.22%
450,000.00USD+126.13%
199,000.00USD-17.08%
240,000.00USD0.00%
240,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Research & Development Expenses of Wize Pharma is 434,000.00 USD in 2020.

Research & Development Expenses of Wize Pharma changed from 492,000.00 USD to 434,000.00 USD, representing a -11.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Wize Pharma

All Key Metrics — Wize Pharma